Shandong Sanyuan Biotechnology (301206.SZ) Earnings Analysis
Shandong Sanyuan Biotechnology (301206.SZ) next reports earnings on 2026-08-28, consensus EPS 0.3933 CNY. Trailing P/E 48.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 301206.SZ next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | 0.3933 CNY |
| Revenue estimate | 0.22B |
301206.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.17 CNY | n/a | n/a | n/a |
| 2025-10-27 | 0.04958 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.1185 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.1367 CNY | n/a | n/a | n/a |
301206.SZ valuation and analyst view
| Trailing P/E | 48.91 |
|---|---|
| Trailing EPS | 0.46294 CNY |
| Price / book | 1.08 |
| Dividend yield | 4.35% |
| Market cap | 4.57B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shandong Sanyuan Biotechnology (301206.SZ)'s next earnings date?
Shandong Sanyuan Biotechnology is next scheduled to report on 2026-08-28, with a consensus EPS estimate of 0.3933 CNY and revenue estimate of 0.22B.
Did 301206.SZ beat earnings last quarter?
Consensus estimate data was not available for 301206.SZ's 2026-04-30 report.
What is 301206.SZ's current P/E ratio and EPS?
301206.SZ trades at a trailing P/E of 48.91 on trailing EPS of 0.46294049 CNY.
What do analysts rate 301206.SZ?
301206.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.